Aims : Actualité Aims en direct - P7 | Bourse Reflex
Accueil > Tags > Aims

  • Toutes les actualités en rapport avec « Aims »

08/09 18:00 Aims - Phase IIa clinical trial for high blood pressure : 50% enrolment four months ahead of schedule and Supervisory Board meeting coming up

08/09 07:30 Aims - US patent granted for use of Genticel's antigen delivery vectors in combination therapy to treat cancer

01/09 18:00 Aims - GENTICEL to meet investors

01/09 08:00 Aims - Global EcoPower strengthens its equity by EUR 1M through issuance of convertible bonds

10/08 18:00 Aims - New EUR 18 million financing aimed at accelerating the development in connected health, particularly in the USA

28/07 18:45 Aims - First-Half 2015 revenue

28/07 18:00 Aims - Business Update - Second Quarter 2015

27/07 10:15 Aims - FINANCIAL YEAR 2014/15 REVENUE

22/07 08:00 Aims - Strengthen financial structure to accelerate development - Maximum potential capital increase of EUR 14.6 million over 3 years upon conversion and exercise of all OCABSA and warrants

20/07 18:00 Aims - 2015 INTERIM REVENUES: EUR 49.1 million

07/07 18:00 Aims - Independent Data Safety Monitoring Board Recommends Continuation per Protocol of Genticel's Phase 2 Clinical Trial of GTL001 (ProCervix), Company's First-in-class HPV Therapeutic Vaccine Candidate

03/07 18:00 Aims - Summary of Genticel's liquidity contract with Oddo Corporate Finance

02/07 18:15 Aims - Genticel CFO, Martin Koch, Appointed CEO to Replace Benedikt Timmerman during Temporary Medical Leave of Absence

01/07 09:10 Aims - Report of the annual general meeting of 30 june 2015

30/06 07:00 Aims - NATUREX unveils its strategic plan " BRIGHT2020 "

25/06 08:30 Aims - Entry into exclusive negotiations with the shareholders of MATIS for a majority takeover

16/06 07:00 Aims - Genticel Receives FDA Clearance of IND Application for U.S. Phase 1 Clinical Trial of GTL001 (ProCervix), Company's First-in-class HPV Therapeutic Vaccine Candidate

10/06 07:00 Aims - Usine IO, the product prototyping and innovation platform, opens its capital to "French Tech Accélération" and Prodways Entrepreneurs

02/06 19:00 Aims - TRONICS AIMS TO BENEFIT FROM MAJOR GROWTH IN SENSORS AND RELATED TECHNOLOGIES FOR HEALTHCARE APPLICATIONS

02/06 17:45 Aims - Quantum Genomics at the 2015 BIO International Convention, June 15-18 in Philadelphia, and at the French Life Sciences Days, June 17-18, 2015, in New York